Aptevo Therapeutics Inc.
APVO· Nasdaq
APVOAptevo Therapeutics Inc.
Filed Aug 10, 2017 · 10-Q · 41 days after period end · 0001564590-17-017132
| Metric | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|
| Revenue | $3.53M | $10.19M | $7.09M |
| Net Income | -$11.19M | -$12.84M | -$17.72M |
| EPS Diluted | -$0.53 | -$0.63 | -$0.88 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aptevo Therapeutics Inc. · CIK 1671584 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 10, 2017 · 41 d after period end
